|
|
Volumn 11, Issue 11, 2003, Pages 1309-1310
|
|
Can mosquitoes be bitten? A new hope for anti-malarial drug design
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2,4 DIMETHYL 5 (2 OXO 1H INDOL 3 YLMETHYLENE) 3 PYRROLEPROPIONIC ACID;
ANTIMALARIAL AGENT;
ARTESUNATE;
ASPARTIC PROTEINASE INHIBITOR;
CYCLIN DEPENDENT KINASE;
CYSTEINE PROTEINASE INHIBITOR;
FOLIC ACID ANTAGONIST;
IMATINIB;
PAMAQUINE;
QUINOLINE DERIVATIVE;
SULFONAMIDE;
SULFONE;
CHROMOSOME ANALYSIS;
CHROMOSOME MUTATION;
DISEASE ACTIVITY;
DRUG DESIGN;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG POTENCY;
DRUG STRUCTURE;
DRUG TARGETING;
EPIDEMIOLOGICAL DATA;
GENETIC ANALYSIS;
HIGH RISK POPULATION;
HUMAN;
INFECTION RISK;
MALARIA;
MALARIA CONTROL;
MORTALITY;
MOSQUITO;
PARASITE TRANSMISSION;
PATHOPHYSIOLOGY;
PLASMODIUM FALCIPARUM;
PRIORITY JOURNAL;
SHORT SURVEY;
STRUCTURE ANALYSIS;
TREATMENT INDICATION;
PLASMODIUM FALCIPARUM;
PROTOZOA;
|
|
EID: 0242711319
PISSN: 09692126
EISSN: None
Source Type: Journal
DOI: 10.1016/j.str.2003.10.011 Document Type: Review |
|
Times cited : (3)
|
|
References (10)
|
